XML 60 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
units
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
units
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Disaggregation of Revenue [Line Items]          
Emerging Markets total countries | units 20   20    
Net sales $ 2,659 $ 2,707 $ 7,204 $ 7,831  
Contract with Customer, Liability [Abstract]          
Contract with Customer, Liability 405   405   $ 400
Change in Contract with Customer, Liability [Abstract]          
Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price 63        
Contract with Customer, Liability, Revenue Recognized 28   84    
United States          
Disaggregation of Revenue [Line Items]          
Net sales 1,560 1,580 4,167 4,462  
International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 1,098 1,126 3,037 3,369  
Emerging Markets [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 278 310 800 925  
Global Endoscopy (Endo) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 475 486 1,265 1,396  
Global Endoscopy (Endo) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 270 277 715 800  
Global Endoscopy (Endo) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 205 209 550 596  
Global Urology (Uro) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 350 359 910 1,033  
Global Urology (Uro) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 251 257 650 737  
Global Urology (Uro) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 99 102 260 297  
Global CRM Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 465 478 1,253 1,467  
Global CRM Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 275 284 738 860  
Global CRM Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 190 194 515 607  
Global Electrophysiology (EP) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 76 81 202 245  
Global Electrophysiology (EP) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 33 38 86 113  
Global Electrophysiology (EP) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 43 43 116 132  
Global Neuromodulation (NM) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 216 222 529 612  
Global Neuromodulation (NM) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 176 183 426 487  
Global Neuromodulation (NM) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 41 39 103 125  
Global Interventional Cardiology (IC) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 586 700 1,714 2,067  
Global Interventional Cardiology (IC) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 255 327 741 942  
Global Interventional Cardiology (IC) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 331 373 973 1,126  
Global Peripheral Interventions (PI) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 416 358 1,148 989  
Global Peripheral Interventions (PI) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 236 195 649 507  
Global Peripheral Interventions (PI) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 179 163 499 482  
Specialty Pharmaceuticals [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 74 23 183 23  
Specialty Pharmaceuticals [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 65 19 162 19  
Specialty Pharmaceuticals [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 10 4 21 4  
BSX Reportable Segments [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 2,584 2,684 7,021 7,807  
BSX Reportable Segments [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 1,496 1,561 4,005 4,443  
BSX Reportable Segments [Member] | EMEA [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 540 535 1,507 1,667  
BSX Reportable Segments [Member] | APAC [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 472 485 1,292 1,403  
BSX Reportable Segments [Member] | Latin America and Canada [Member]          
Disaggregation of Revenue [Line Items]          
Net sales $ 77 $ 102 $ 217 $ 294